Director, New Product Planning
Deciphera Pharmaceuticals
Summary
Deciphera Pharmaceuticals is seeking a highly motivated individual to join the New Product Planning (NPP) team. In this visible role, you will collaborate across multiple functions to implement best commercial practices, foster communication, and inspire collaboration for the Deciphera portfolio. This role reports to the Executive Director, New Product Planning.
Job description
Overview
Deciphera Pharmaceuticals is seeking a highly motivated individual to join the New Product Planning (NPP) team. In this visible role, you will collaborate across multiple functions to implement best commercial practices, foster communication, and inspire collaboration for the Deciphera portfolio. This role reports to the Executive Director, New Product Planning.
Key Responsibilities
- Develop market entry and program strategies for key assets.
- Provide commercial evaluation and strategic input for lifecycle management opportunities.
- Collaborate with IR/corporate communications for external messaging.
- Identify and assess opportunities and risks, translating insights into actionable strategies.
- Support program strategy development and execution to maximize market potential.
- Communicate commercial insights and strategy to cross-functional teams and senior leadership.
- Lead competitive intelligence collection and communication.
- Enhance NPP function processes and capabilities.
Requirements
- BS/BA in business, life sciences, or related discipline
- Advanced degree preferred
- 12+ years of biopharmaceutical industry experience
- 3+ years in new product planning or related roles
- Strong scientific knowledge and clinical acumen
- Experience with market research and competitive intelligence
- Exceptional strategic thinking, leadership, and communication skills
- Ability to manage multiple priorities and demonstrate attention to detail
- Passion for continual learning and development
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Life Insurance
- Flexible Spending Account
- Annual Performance Bonus
- Long-Term Incentive Plan
- Parental Leave
- Family Planning Benefits
Company overview
Deciphera Pharmaceuticals is a commercial-stage biopharmaceutical company headquartered in Waltham, Massachusetts, with research facilities in Lawrence, Kansas. Founded in 2003, the company specializes in discovering, developing, and commercializing innovative medicines for cancer treatment. As a member of the ONO Group since June 2024, Deciphera leverages its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a diverse portfolio of oncology therapeutics. The company's flagship product, QINLOCK®, is an approved switch-control inhibitor for fourth-line gastrointestinal stromal tumor (GIST), while its pipeline includes multiple clinical-stage candidates targeting various cancers and rare diseases. Deciphera's unique approach targets the switch pocket region of kinases, aiming to generate higher and more durable response rates compared to traditional kinase inhibitors. With a global presence spanning the United States, Europe, and Asia, the company maintains a patient-centric focus, developing transformational medicines to improve the lives of people living with cancer.